HKB99, an allosteric inhibitor of phosphoglycerate mutase 1, suppresses invasive pseudopodia formation and upregulates plasminogen activator inhibitor-2 in erlotinib-resistant non-small cell lung cancer cells.
第一作者:
Qian,Liang
第一单位:
Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
作者:
主题词
蒽类(Anthracenes);抗肿瘤药(Antineoplastic Agents);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);抗药性, 肿瘤(Drug Resistance, Neoplasm);酶抑制剂(Enzyme Inhibitors);基因敲低技术(Gene Knockdown Techniques);人类(Humans);细胞内信号肽和蛋白质类(Intracellular Signaling Peptides and Proteins);肺肿瘤(Lung Neoplasms);磷酸甘油酸酯变位酶(Phosphoglycerate Mutase);伪足(Pseudopodia);磺胺类(Sulfonamides);增量调节(Up-Regulation)
DOI
10.1038/s41401-020-0399-1
PMID
32404981
发布时间
2022-01-02
- 浏览3

Acta pharmacologica Sinica
115-119页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文